Telmisartan for prevention of cardiovascular events
Fichet, Jérôme.; Bressolle, C.
New England Journal of Medicine 360(3): 302-303; Author Reply 303
2009
ISSN/ISBN: 0028-4793 PMID: 19148963 Document Number: 630189
Document emailed within 1 workday
Related Documents
Hiatt, W.R. 2008: Aspirin for prevention of cardiovascular events Bmj 337: A1806Rocha, E.; Mello e Silva, A.; Nogueira, P. 2003: Relation between hypertension and cardiovascular events--implications for coronary prevention Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(10): 1215-1224
Guo, Y.F. 2019: Effects of aspirin on primary prevention of cardiovascular events in patients with hypertension Zhonghua Nei Ke Za Zhi 58(4): 249-251
Nordt, T. 2001: Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project Der Internist 42(12): 1705-1707
Nilsson, P.M.; Håkansson, J. 2005: Amlodipine better than atenolol in hypertension. More efficient prevention of the mortality and cardiovascular events according to the ASCOT trial Lakartidningen 102(41): 2922-2923
Klomp, C.M.C.; ten Cate, H.; Stehouwer, C.D.A.; Schaper, N.C. 2009: Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events Nederlands Tijdschrift Voor Geneeskunde 153: A109
Iavelov, I.S. 2006: Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials) Kardiologiia 46(3): 75-76
Long Term Intervention With Pravastatin, I.Ischaemic Disease Study Group 1998: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels New England Journal of Medicine 339(19): 1349-1357
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
García, Félix.Miguel.; García Ortiz, A.; Montero Alonso, Mía.José. 2006: Reducing cardiovascular risk in a table is not equivalent to reducing cardiovascular events Atencion Primaria 38(7): 417; Author Reply 417-8
Wade, A.S.; Enel, C.; Lagarde, E. 2005: Prevention of HIV and other STIs in rural Senegal: a study of prevention-related events collected by sentinel observers SaharaJ: Journal of Social Aspects of HIV/AIDS 2(2): 251-257
Simoons, M.L.; Vos, J.; Deckers, J.W.; de Feyter, P.J. 1995: Coronary artery disease: prevention of progression and prevention of events European Heart Journal 16(6): 729-733
Gortner, S.R.; Jenkins, L.S. 1990: Recovery after cardiovascular events. Overview Heart and Lung: the Journal of Critical Care 19(5 Pt 1): 471-473
Nakamura, H.; Yamashita, T. 2002: Predictive value of cardiovascular events by high sensitivity CRP Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 916-921
Wise, J. 2015: Shingles is linked to increased risk of cardiovascular events Bmj 351: H6757
Stevermer, J.J. 2003: Does C-reactive protein predict cardiovascular events in women better than LDL? Journal of Family Practice 52(3): 185-186
Overbeck, P. 2012: Basal insulin has a "neutral effect" on cardiovascular events MMW Fortschritte der Medizin 154(12): 24